Biolase (BIOL) Announces Pricing of $1.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

December 6, 2023 1:48 PM EST Send to a Friend
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it has entered into a securities purchase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login